Testing an oral cholera vaccine in healthy adults
Part of Infections clinical trials.
This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old and in good health.
- You cannot have received a cholera vaccine or had cholera before.
- You must not be pregnant, breastfeeding, or planning to become pregnant for 3 months after vaccination.
- You cannot have any stomach or immune system problems.
- You must not work with young children, food, or immunocompromised patients.
- You cannot have taken antibiotics or certain vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new oral vaccine designed to protect against cholera. It is for healthy adults aged 18-45 who want to help evaluate the vaccine's safety and immune response. Participation involves receiving the vaccine and attending follow-up visits.
This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.
This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
This study tests an oral cholera vaccine to see how it affects your gut bacteria, inflammation, and bowel habits. Participation may help researchers understand how the vaccine works in real-world populations.
This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.
Hear when a new Cholera Vaccination Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.